Skip to main content

Treatment patterns for metastatic castration-resistant prostate cancer (mCRPC) in oncology (ONC) urology (URO) practices: Data from the PROCEED registry.

Publication ,  Conference
Vogelzang, NJ; Armstrong, AJ; Higano, CS; Sartor, AO; Pieczonka, CM; Concepcion, RS; Tutrone, RF; Olsson, CA; Bailen, JL; Penson, DF; Chang, NN ...
Published in: Journal of Clinical Oncology
May 20, 2016

Duke Scholars

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2016

Volume

34

Issue

15_suppl

Start / End Page

e16503 / e16503

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vogelzang, N. J., Armstrong, A. J., Higano, C. S., Sartor, A. O., Pieczonka, C. M., Concepcion, R. S., … Cooperberg, M. R. (2016). Treatment patterns for metastatic castration-resistant prostate cancer (mCRPC) in oncology (ONC) urology (URO) practices: Data from the PROCEED registry. In Journal of Clinical Oncology (Vol. 34, pp. e16503–e16503). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2016.34.15_suppl.e16503
Vogelzang, Nicholas J., Andrew J. Armstrong, Celestia S. Higano, A Oliver Sartor, Christopher Michael Pieczonka, Raoul S. Concepcion, Ronald F. Tutrone, et al. “Treatment patterns for metastatic castration-resistant prostate cancer (mCRPC) in oncology (ONC) urology (URO) practices: Data from the PROCEED registry.” In Journal of Clinical Oncology, 34:e16503–e16503. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.e16503.
Vogelzang NJ, Armstrong AJ, Higano CS, Sartor AO, Pieczonka CM, Concepcion RS, et al. Treatment patterns for metastatic castration-resistant prostate cancer (mCRPC) in oncology (ONC) urology (URO) practices: Data from the PROCEED registry. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. e16503–e16503.
Vogelzang, Nicholas J., et al. “Treatment patterns for metastatic castration-resistant prostate cancer (mCRPC) in oncology (ONC) urology (URO) practices: Data from the PROCEED registry.Journal of Clinical Oncology, vol. 34, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2016, pp. e16503–e16503. Crossref, doi:10.1200/jco.2016.34.15_suppl.e16503.
Vogelzang NJ, Armstrong AJ, Higano CS, Sartor AO, Pieczonka CM, Concepcion RS, Tutrone RF, Olsson CA, Bailen JL, Penson DF, Chang NN, LIll JS, Tyler RC, Cooperberg MR. Treatment patterns for metastatic castration-resistant prostate cancer (mCRPC) in oncology (ONC) urology (URO) practices: Data from the PROCEED registry. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. e16503–e16503.

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2016

Volume

34

Issue

15_suppl

Start / End Page

e16503 / e16503

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences